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1. Introduction 
Fear-avoidance and reward-seeking are necessary motivations to guide survival; however, 
both can lead to maladaptive behavior when expressed inappropriately, manifesting as 
anxiety disorders and drug addiction. Both disorders are a major worldwide public health 
concern with a high co-morbidity (M. S. O'Brien et al., 2005; Wasserman et al., 1997). 
Specifically, the World Health Organization (WHO) pin-pointed generalized anxiety 
disorder and substance abuse as the most common mental disorders across the world, 
ranking them highly as a cause of disease burden (WHO, 2001). Furthermore, in the recent 
United States National Comorbidity Survey Replication study, it was reported that 18.1% 
and 8.9% of adults met the 12-month Diagnostic and Statistical Manual of Mental Disorders 
(DSM-IV; American Psychiatric Association, 2000) criteria for an anxiety or substance abuse 
disorder, respectively (Kessler et al., 2005). These staggering statistics also highlight the 
economic costs of anxiety disorders and substance abuse. For example, one estimate puts the 
yearly economic cost of alcohol abuse to be $148 billion, and the economic cost of harmful 
drug use and dependence has been estimated to be $98 billion in the United States alone 
(Harwood et al., 1998). Another study reported the economic cost of anxiety disorders to be 
$42 billion in the United States (Greenberg et al., 1999). 
Given the prevalence and the financial burden of anxiety disorders and substance abuse, a 
significant amount of research has been dedicated to finding effective treatments for those 
disorders. At present, the use of pharmacological agents has become a standard approach to 
attempt to ameliorate aspects of drug addiction and anxiety (Jupp & Lawrence, 2010; 
Reinblatt & Riddle, 2007). Unfortunately, the prevalence of these disorders still remain 
extremely high, although pharmacotherapy may be an effective approach to the treatment of 
drug addiction and anxiety disorders for some individuals. Furthermore, relapse is high in 
both substance abuse and anxiety disorders, even after pharmacotherapy (C. P. O'Brien, 
1997b; Rachman, 1989). Thus, it has been suggested that cognitive-behavioral therapies that 
rely on learning mechanisms may potentially lead to more effective treatments for both 
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types of disorders (Myers et al., 2011; Sutton et al., 2003). Therefore, much effort has been 
placed in finding an effective pharmacotherapy to combine with cognitive-behavioral 
therapies to effectively treat these mental disorders and prevent their relapse (M. Davis et 
al., 2006; Hofmann, 2007). 
The importance of cognitive-behavioral therapies in treating anxiety disorders and 
substance abuse has been highlighted following observations that learning and memory 
processes play a significant role in acquisition and relapse in these disorders both in clinical 
settings and in the laboratory (Bouton et al., 2001; Mineka & Zinbarg, 1996; Rasmusson & 
Charney, 1997). For example, a common form of anxiety, posttraumatic stress disorder 
(PTSD), develops in vulnerable people following exposure to a traumatic event, and it is 
believed that these symptoms arise in part through a learning process in which cues present 
at the time of trauma acquire the ability to elicit fear (M. Davis & Whalen, 2001). Those cues 
can generalize over time to other settings and trigger pervasive fear and anxiety in 
inappropriate situations (Rothbaum & M. Davis, 2003). Drug addiction also involves 
learning - cues that are associated with the rewarding properties of a drug can trigger drug 
use in an individual (Rescorla, 1988; Robinson & Berridge, 2001). For example, drug 
paraphernalia such as a syringe, can trigger powerful drug craving that contributes to the 
maintenance of, and relapse to, drug use (A. R. Childress et al., 1986). Discovering that 
memory processes underlie anxiety disorders and drug addiction has not only led to a more 
successful modeling of anxiety and drug use using rodents in the laboratory, but also has 
guided pharmacological research. That is, considerable progress has already been made in 
delineating the neural bases of memory storage (Kandel, 2001, 2009), and research on 
anxiety disorders and drug addiction is now focused on characterizing the specific effects of 
proteins that have already been identified to be involved in general learning and memory. 
Mitogen-activated protein kinase (MAPK), in particular, refers to the entire superfamily of 
signaling cascades including the extracellular signal-regulated kinase (ERK) (Sweatt, 2001). 
The MAPK cascade is distinguished by a unique core series of three kinases: the first is MAP 
kinase kinase kinase (MAPKKK) that phosphorylates (i.e., activates) the second, a MAP 
kinase kinase (MEK). MEKs in turn activate a MAP kinase. The two main isoforms of MAPK 
are ERK1 and ERK2, which are 44 kDa and 42 kDa respectively (L. Lu et al., 2006). MAPK is 
well-known for its critical role in learning and memory as well as cellular growth, 
differentiation and survivability (Ahn & Krebs, 1990; Hoshi et al., 1988; Impey et al., 1999; 
Kornhauser & Greenberg, 1997; Sweatt, 2001). The present chapter will provide an in-depth 
review of the existing findings on the relationship between MAPK and fear and drug-
seeking behavior using animal models. The aim of our chapter is for the audience to gain a 
better understanding of the significance of MAPK in anxiety disorders and drug addiction 
in order to facilitate the development of pharmacological adjuncts to assist in treatment of 
these disorders. The next section will first briefly review the research that revealed the 
molecular cascade underlying memory storage and formation, and the importance of MAPK 
signaling in that cascade. 
2. The molecular biology of memory formation and storage 
Memory formation has long been though to be sub-served by a mechanism called 'synaptic 
plasticity', which refers to molecular and morphological changes that occur in dendrites and 
axons that either enhances or reduces the effectiveness of electrical and/or chemical 
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communication between neurons across synapses (Konorski, 1948). Due to the seminal work 
on Aplysia by the Nobel laureate Kandel and his colleagues, we now know that synaptic 
plasticity requires various molecular cascades that ultimately result in modifications of 
synaptic structure and efficacy (Kandel 2001, 2009). The best-studied mechanism that may 
potentiate these changes is N-methyl-D-aspartate receptor (NMDAR)-dependent long-term 
potentiation (LTP) (Sweatt, 1999). LTP refers to a lasting enhancement of the strength of 
synaptic connection as a result of brief repetitive activation of that synaptic pathway (Bliss & 
Collingridge, 1993). For example, experimentally-induced LTP involves a few trains of high-
frequency stimuli to the connection between two neurons (Huang & Kandel, 1994). We 
know that LTP is important for memory storage because LTP disruption has been shown to 
impair memory consolidation in a region-specific manner. In the hippocampus, for example, 
antagonism of NMDARs impairs both LTP induction as well as hippocampal-dependent 
spatial learning in rats (Morris et al., 1986).  
NMDA-dependent LTP is generally divided into three phases: short-term potentiation (or 
initial LTP), early LTP (E-LTP), and late LTP (L-LTP) (Sweatt, 1999). Short-term potentiation 
refers to the first stage of LTP that is independent of protein kinase activity for its induction 
or expression (Roberson et al., 1996). E-LTP starts at around 30 mins upon induction and 
typically lasts 60-90 mins. E-LTP requires protein kinase activation but is independent of 
gene transcription and protein synthesis (Frey et al., 1993). The last phase of LTP, L-LTP, 
lasts many hours and requires gene transcription and protein synthesis for its maintenance, 
and such processes are critical in the modification of synapses (Frey, et al., 1993). Although 
it appears that short-term potentiation is necessary for the subsequent phases of LTP, not 
much is known about the mechanisms underlying it (Roberson et al., 1996), therefore, the 
present review will focus on the molecular cascade related to E-LTP and L-LTP.  
Typically, excitatory synaptic transmission occurs chemically via presynaptic release of 
glutamate into the synapse. Glutamate then binds to 2-amino-3-(5-methyl-3-oxo-1,2- oxazol-
4-yl)propanoic acid receptors (AMPARs) on the postsynaptic membrane, triggering the 
influx of positively-charged of sodium ions into the postsynaptic neuron (Agranoff & Siegel, 
1999). Such influx of ions causes depolarization of the cell, called the excitatory postsynaptic 
potential (EPSP). Likewise, the induction of E-LTP begins with NMDA receptor activation 
that leads to an influx of positively-charged calcium ions through ligand- and voltage-gated 
calcium channels into the postsynaptic neuron, causing depolarization (Ascher & Nowak, 
1986). If calcium influx does not reach a threshold, E-LTP fails to occur (Lynch, 2004). The 
rapid rise in intracellular calcium concentration initiates the short- or long-lasting activation 
of several proteins that appear to be necessary for E-LTP. For example, blocking 
phosphorylation (i.e., activation) of calcium/calmodulin-dependent protein kinase II 
(CaMKII) and protein kinase C (PKC) impairs the induction and maintenance of E-LTP 
(Sweatt, 1999). Protein kinase A (PKA) and mitogen-activated protein kinase (MAPK) 
phosphorylation also contribute to the maintenance of E-LTP (Lynch, 2004; Sweatt, 1999). 
Additionally, protein kinase Mζ (PKMζ), which is calcium independent, becomes activated 
during the maintenance of E-LTP. Those protein kinases carry out phosphorylation of 
existing AMPARs to increase their activity, as well as mediating insertion of AMPARs into 
the postsynaptic membrane (Malenka & Bear, 2004).  
As mentioned previously, L-LTP is a natural extension of E-LTP. That is, long-lasting 
activation of some of the protein kinases mentioned above can induce L-LTP. L-LTP can last 
many hours, even days, and requires gene transcription and de novo protein synthesis in the 
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postsynaptic neuron (Frey et al., 1988; Lynch, 2004; Stanton & Sarvey, 1984). Those 
characteristics distinguish L-LTP from E-LTP because E-LTP does not require either. For 
example, administration of the protein synthesis inhibitor anisomycin blocks L-LTP, but not E-
LTP, in the hippocampus (Frey et al., 1988). Gene transcription necessary for L-LTP is 
triggered by the persistent activation of MAPK. MAPK can translocate to the nucleus and 
activate nuclear molecules such as cyclic adenosine monophosphate (cAMP)-response element 
binding protein (CREB), which is a gene transcription factor (Lynch, 2004; Sweatt, 1999). ERK-
mediated changes in transcription factor activity can ultimately result in the protein synthesis 
and morphological changes in neurites observed in L-LTP (Figure 1). For example, activity-
regulated cytoskeletal element (Arc; also termed Arg3.1), is an immediate early gene that 
requires MAPK for its transcription (Chotiner et al., 2010). Arc has been widely implicated in 
experience-dependent synaptic plasticity because Arc is tightly coupled to the activation of 
signaling pathways implicated in learning, rather than being involved in normal cellular 
activity (Fletcher et al., 2006). Indeed, Arc expression in the hippocampus is critical for both 
LTP maintenance and the formation of hippocampus-dependent memory (Guzowski et al., 
2000) and MEK inhibition suppresses experience-induced Arc mRNA levels (Chortiner et al., 
2010). Further, Arc transcription can lead to protein synthesis via activation of receptors such 
as Notch (Alberi et al., 2011). Notch receptors and ligands are transmembrane proteins present 
at synapses that play a major role in changing neurite structure (Sestan et al., 1999). Blocking 
any one of the steps in the molecular cascade mentioned above impairs memory consolidation 
and or/learning and LTP (Kandel, 2001). Taken together, it appears that formation of long-
term memory is linked to a molecular cascade involving pre-synaptic glutamate release, 
NMDA-mediated calcium entry, activation of protein kinases, gene expression and 
transcription, and protein synthesis (Figure 1).  
 
Fig. 1. Schematic diagram illustrating intracellular signalling pathway involved in the 
neuronal plasticity implicated in the formation of memory. 
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It is important to note that MAPK is critical for both L-LTP and E-LTP; MEK inhibitors 
significantly attenuate E-LTP and block L-LTP (S. Davis, Salin et al., 2000; English & Sweatt, 
1997; Schafe et al., 2008; Sweatt, 1999; Wu et al., 1999). That is, MAPK signaling appears to 
be a molecular link between E-LTP and L-LTP. Indeed, many signaling cascades involved in 
E-LTP, including CaMKII and PKC, can converge on ERK (Kelleher et al., 2004). The strong 
possibility of MAPK being a link between E-LTP and L-LTP has significant implications for 
its role in memory. Historically, E-LTP and L-LTP are believed to be mechanisms sub-
serving short-term memory (STM) and long-term memory (LTM), respectively, because 
both E-LTP and STM endure for a few hours, whereas L-LTP persists for many hours and 
even days, similar to LTM (Kandel, 2009). Thus, blockade of MAPK may sever any possible 
link between STM and LTM, and critically affect memory consolidation and storage. 
Therefore, it is not surprising that much attention has been given to the role of MAPK in 
animal models of anxiety disorders and drug addiction in the past couple of decades, as it 
became increasingly apparent that memory processes underlie these disorders.  
3. MAPK in conditioned fear  
Among the early advocates of the idea that anxiety disorders emerge from traumatic 
memories were Watson and Rayner (1920) who proposed that humans are born with very 
few 'emotional reaction patterns', and the way in which stimuli come to evoke emotion 
throughout one’s life is through learning, or conditioning, processes. That is, animals learn 
to respond in distinct ways to different stimuli according to previous experiences with those 
stimuli. According to this notion, simple aversive learning and memory processes are 
critical for triggering anxiety disorders. To support this idea, in the famous ‘little Albert’ 
experiment, a baby boy was conditioned to fear a rat by sounding an aversive loud noise 
each time the baby touched the rat (Watson & Rayner, 1920). Before this experience, the 
baby was keen to touch and play with the rat. After the experience, however, the baby 
displayed signs of fear and anxiety (e.g., crying and reaching for mum) when in the 
presence of the rat. The simple pairing of the rat and the aversive noise induced fear 
learning in little Albert. This associative learning is referred to as classical or Pavlovian 
conditioning because Pavlov was the first to demonstrate such associative learning in 
animals (Konorski, 1948; I. P. Pavlov, 1927). Typically, Pavlovian fear conditioning involves 
pairings of a conditioned stimulus (CS), such as a tone, with an aversive unconditioned 
stimulus (US), such as a footshock. The CS can be discrete or diffuse, such as a localized 
light or a context, respectively. Initially, the CS is a neutral stimulus that has little effect on 
animals. On the other hand, the US is a stimulus that already elicits fear responses via 
physiological, autonomic and behavioral changes. These fear responses triggered by the US 
are referred to as unconditioned responses. When the CS and the US are repeatedly paired, 
the CS starts to elicit such autonomic and behavioral fear responses on its own without the 
US, and these responses are referred to as conditioned responses (CRs). 
Such fear conditioning is readily acquired in animals, and is not easily forgotten (Gale et al., 
2004). Because this form of learning can be acquired even in very immature animals (e.g., 12-
day-old rats; (Sullivan et al., 2000), Pavlovian conditioning provides a model for 
investigating the neurobiological bases of anxiety disorders, which often emerge during 
childhood/early adolescence in humans (Kessler, et al., 2005; Newman et al., 1996). Apart 
from Pavlovian conditioned fear, however, there are other laboratory models of anxiety 
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disorders. For example, Grillon and colleagues proposed that anxiety disorders are caused 
by unpredictable aversive events that lead to hyperactive fear responses that are generalized 
across different situations and environments (Grillon et al., 2004). Specifically, if an aversive 
US is not signalled reliably by a discrete CS, subjects show more fear to the training context 
compared to subjects that received the US signalled reliably by a CS. The elevated fear to the 
context exhibited by the unsignalled group reflects generalized anxiety according to this 
theory. Another laboratory model for anxiety disorders relies on the concept of ‘unlearned’ 
fear, which refers to the innate fear that animals have to various stimuli without any 
previous learning experiences with these stimuli (Boulis & M. Davis, 1989). Unlearned fear 
is triggered by a diffuse cue rather than a specific cue; therefore, unlearned fear can serve as 
a good model for anxiety disorders that may not be triggered by a specific object or a 
situation. Additionally, unlearned fear may explain some specific phobias that may be an 
exaggerated, debilitating form of natural fear (e.g. acrophobia).  
Nevertheless, Pavlovian fear conditioning is the most utilized neurobiological model for 
anxiety, as it reflects the most common form of anxiety disorder, namely post-traumatic 
stress disorder (PTSD). This is partly because this preparation allows a variety of discrete 
stimuli to be used as the CS or the US, so that the role of each sensory modality and different 
neural structures in learning can be examined. Also, Pavlovian conditioning is easily 
acquired in many different animals across a range of different ages, unlike contextual 
conditioning in Grillon’s model for anxiety (Grillon et al., 2004). Further, considering that 
anxiety disorders may be normal fear gone astray (Rosen & Schulkin, 1998), using Pavlovian 
conditioning as a model for fear learning provides a tool for understanding how the fear 
system works. It is no surprise then since Pavlov (1927) researchers have investigated the 
neurobiology underlying conditioned fear. Although much work has been done with the 
rat, it should be noted that similar neural processes are involved in learned fear across a 
range of species (Davis, 2000; LeDoux, 2000; Price, 2003). These findings have pin-pointed 
the amygdala as a central structure that is essential for the acquisition, storage and 
expression of conditioned fear.  
The amygdala is made up of many sub-nuclei including the central (CeA) and basolateral 
(BLA) nuclei. The BLA is further divided into basal (BA) and lateral (LA) nuclei. During fear 
conditioning, perceptual (e.g., olfactory, visual) and somatosensory (e.g., noxious) 
information regarding the CS (discrete as well as contextual information) and US from 
hippocampal, cortical and thalamic structures is transmitted to the LA (LeDoux, 1993; 
LeDoux et al., 1990; McDonald et al., 1996; Price, 2003; C. Shi & Davis, 2001). As the result of 
CS-US convergence, neuronal activity in the LA is modified (Quirk et al., 1997; Quirk et al., 
1995; Repa et al., 2001). Interestingly, once the CS and the US have been associated, the fear 
memory is stored in the BLA via similar intracellular molecular changes involved in LTP 
discussed earlier (Bailey et al., 1999; Campeau et al., 1991; Farb et al., 1992; Lee & Kim, 1998; 
C. H. Lin et al., 2001; Maren et al., 2003). Further, in vitro electrophysiological recordings 
show that LTP in the BLA is blocked by inhibition of MAPK activity without affecting basal 
transmission (Huang et al., 2000; Schafe et al., 2000). Hence, fear conditioning results in an 
enhanced functional and structural connectivity between sensory pathways and the BLA, 
such that future presentation of the CS alone is sufficient to activate the BLA. Such enhanced 
functional and structural connectivity requires MAPK signaling, as evidenced by many 
empirical demonstrations of the relationship between MAPK and conditioned fear.  
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3.1 The role of MAPK in the acquisition of conditioned fear 
The involvement of MAPK in conditioned fear was initially illustrated by correlational 
studies that showed increases in phosphorylated MAPK (pMAPK) following fear 
conditioning via Western blotting and immunohistochemistry (Atkins et al., 1998; Gresack et 
al., 2009; Schafe & LeDoux, 2000; Sindreu et al., 2007). In one of the first studies examining 
the role of MAPK and conditioned fear, Sweatt and his colleagues first gave context-shock 
or cue-shock training to rats (Atkins et al., 1998). The memory of conditioned fear was 
assessed by CS-elicited freezing fear 24 hours later. Freezing is a species-specific defense 
response in rodents, and is characterized by an immobile, crouching position accompanied 
by hypervigilance, and is operationally defined as the absence of movement other than that 
required for respiration (Blanchard & Blanchard, 1972). At test, both context- and cue-shock 
trained rats exhibited robust freezing to the context or the cue, respectively. In a follow-up 
experiment, Western blotting revealed significant increases in pMAPK in the hippocampus 
(a known neural structure important for contextual and spatial learning) of rats that 
received either context-shock or cue-shock training compared to sham-trained rats that were 
merely placed in the context. This increase was significant 60 mins following conditioning, 
but not 1 min or 24 hours following conditioning. Interestingly, pre-conditioning systemic 
injection of the NMDA antagonist MK801 blocked this conditioning-related increase in 
pMAPK, as well as impairing both cue- and context-elicited freezing in a separate group of 
rats tested 24 hrs later. This finding suggests that the increase in MAPK phosphorylation in 
the hippocampus following fear conditioning is part of the NMDA-dependent molecular 
cascade that may be responsible for the formation of long-term memory. Additionally, 
Sindreau et al., (2007) also reported increased pERK in the CA1 area of the hippocampus 
following contextual fear conditioning in mice. Peak pERK was detected 30 mins following 
conditioning, which is different from Atkins et al. (1998) but can possibly be attributed to 
inter-species differences. Importantly, double immuno-labeling using the neuronal marker 
NeuN, interneuron marker GAD69, or astrocyte marker GFAP revealed that learning-
induced ERK activation was exclusively neuronal (CA1 pyramidal cells) and not glial or 
interneuronal (Sindreu, et al., 2007). Further, activation of MAPK, PKA and CREB kinase 
was observed in the same neurons, further supporting that the molecular cascade 
underlying memory is likely to be involved in contextual fear memory consolidation. 
The first study to examine phosphorylation of MAPK in the amygdala, a structure central to 
both contextual and cued fear conditioning, reported that tone-shock training significantly 
increased pMAPK-labelled neurons in the LA, compared to tone-only and shock-only 
control groups (Schafe & LeDoux, 2000). Additionally, Western blot revealed increases in 
phosphorylated ERK (pERK) in the conditioned group. Consistent with Atkins et al. (1998), 
both immunohistochemical and western blot data showed that pMAPK levels were the 
strongest 60 mins following conditioning. However, no rats were tested for their long-term 
memory following conditioning or tone-/shock-only training, making it difficult to attribute 
the increases in pMAPK/pERK in the LA to associative fear memory formation. Another 
study has provided such evidence for increases in pMAPK/pERK levels in the amygdala 
following Pavlovian fear conditioning as well as another type of fear learning. Specifically, 
Radwanska et al. (2002) trained rats on a two-way active avoidance procedure, in which 
footshocks were given in a compartment of a two-compartment shuttle box. During each 
training trial the auditory CS was presented and the rat could 'avoid' the shock by moving 
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into the other compartment within 5 seconds of CS onset. Failure to change the 
compartment within this time led to the onset of footshock US. Rats were then either 
sacrificed for immunohistochemistry, or were tested for avoidance memory 24 hours later. 
At test, rats showed good retention of two-way avoidance learning by showing increased 
avoidance behavior upon CS-onset at test compared to training. Increased pERK was also 
observed in the ventral portion of the dorsal LA compared to naive rats. In a separate, but 
identical experiment, increased activation of the immediate early-gene, Fos, was also 
observed in the same area. These results were replicated using Pavlovian fear conditioning 
(Di Benedetto et al., 2009; Radwanska et al., 2002). The authors suggested that the increases 
in pERK and c-Fos in the ventral-dorsal LA may be indicative of fear memory storage as a 
prior electrophysiology study observed that this specific area of the amygdala contained 
neurons that displayed extinction-resistant firing patterns (Repa et al., 2001).  
MAPK phosphorylation in the LA as a potential marker for storage of fear memory is 
supported by a very recent study that examined fear memory retrieval and forgetting in 
developing rats (Kim et al., 2012). In that study, a memory phenomenon called 'infantile 
amnesia' was examined, which refers to the more rapid forgetting displayed by young 
animals compared to older animals (Campbell & Spear, 1972). Typically, no age differences 
in retention are observed when testing occurs soon after training, indicating that animals of 
all ages are equally able to acquire and express memory. However, when testing occurs after 
a delay, retention increases dramatically with maturation. This general finding has since 
been replicated numerous times, and is of substantial biological significance because it is an 
ubiquitous phenomenon that occurs in all altricial species, including humans (for a review, 
see Campbell & Spear, 1972). Interestingly, infantile amnesia reflects a failure to retrieve the 
fear memory at test because various pretest ‘‘reminder’’ treatments are able to reinstate the 
memory. For example, a single pre-test shock unconditioned stimulus (US) can reverse 
infantile forgetting (Campbell & Jaynes, 1966; Kim & Richardson, 2007a, 2007b). Kim et al. 
(2012) first showed that when postnatal day (P) 16 and 23 rats receive tone CS-shock 
pairings, both ages exhibited similar levels of conditioned fear when tested immediately 
after conditioning; when tested after 2 days, however, P16 rats showed poor CS-elicited 
freezing relative to P23 rats. When rats were assessed for pMAPK after test, both P23 and 
P16 rats given paired presentations exhibited significant elevation of pMAPK-
immunoreactive (ir) neurons in the BLA compared to rats given unpaired presentations, 
despite P16 rats showing poor CS-elicited freezing (i.e., forgetting). In contrast, only the P23-
paired group showed an elevated number of pMAPK-ir neurons in the medial prefrontal 
cortex (mPFC), indicating that MAPK phosphorylation in the mPFC tracks memory 
expression. These findings provided initial evidence suggesting that while the mPFC is 
involved in memory retrieval, MAPK phosphorylation in the BLA may be a persisting 
neural signature of fear memory storage that is forgotten but can be retrieved with reminder 
treatments. 
The studies described above show whether learning or memory retrieval is followed by 
MAPK activation, providing correlational evidence for the involvement of MAPK in fear 
memory consolidation. In a different type of correlational study, Gresack et al. (2009) used 
sex differences to examine whether stronger memory is associated with greater MAPK 
activation following learning because it is well-established that there are sex differences in 
contextual fear conditioning due to differences in hippocampal dendritic and synaptic 
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morphology and cell excitability (Juraska, 1998; Madeira et al., 1991; M. D. Smith et al., 
2002). It was first shown that male rats exhibit more long-term retention of contextual fear 
conditioning than female rats, as tested by context-elicited freezing 24 hours following 
context-shock training (Gresack, et al., 2009). Western blot then showed that pERK levels in 
ventral, but not dorsal, hippocampus were higher in males than females, relative to same-
sex controls, 60 minutes following fear conditioning. Further, there were no sex differences 
in context conditioning-induced pERK increases in the amygdala, suggesting that the sex 
difference in pERK may be restricted to the ventral hippocampus. These findings imply 
different strengths of memory may be subserved by quantitative differences in MAPK 
activation. 
Taken together, the correlational studies show phosphorylation of MAPK following fear 
conditioning and expression. However, they do not indicate whether MAPK is necessary for 
long-term fear memory. The direct upstream activator of MAPK is MEK, and various fear 
studies using MEK inhibitors support the hypothesis that MAPK regulation is necessary for 
memory consolidation (Atkins et al., 1998; Izquierdo et al., 2000; Schafe et al., 1999; Selcher 
et al., 1999). First, it was shown that systemic injection of SL327, a MEK inhibitor that crosses 
the blood-brain barrier (Favata et al., 1998), dose-dependently decreased pMAPK in the 
hippocampus in rats (Atkins et al., 1998). More importantly, systemic injection of SL327 one-
hour before fear conditioning significantly impaired both cue- and context-elicited freezing 
when tested 24 hours later, compared vehicle injection. Open-field and shock sensitivity 
tests indicated that the effects of SL327 were not due to changes in anxiety levels or sensory 
perception. Importantly, memory impairment was not due to state-dependent mechanisms 
because injection of SL327 immediately after conditioning also blocked cue- and context-
freezing. These findings were replicated in mice (Selcher et al., 1999). Finally, an 
intracerebroventricular (ICV) infusion study using the selective MEK inhibitor PD098059 
(Seger & Krebs, 1995), definitively showed that memory impairments due to inhibition of 
MAPK activity was central rather than peripheral. Specifically, ICV infusion of PD098059 
prior to tone-conditioning significantly reduced both tone- and context-elicited freezing 
when tested 24 hours, but not 1 hr, after conditioning (Schafe et al., 1999). The failure to see 
any memory deficit at the 1 hr test strongly suggests that MAPK activation during 
conditioning is necessary for LTM but not for STM. This is consistent with the idea that 
MAPK is particularly important for L-LTP, a putative neural mechanism underlying long-
term memory. It should also be noted that in all three studies mentioned in this paragraph, 
there were no discernible effects of the drug during the conditioning session. 
Since Schafe et al. (1999), quite a few studies have examined the necessity of MAPK 
activation in various neural structures that form the neural circuitry underlying conditioned 
fear, including the BLA, hippocampus, cortical and thalamic structures.  Schafe et al., (2000) 
showed that bilateral intra-BLA infusion of the selective MEK inhibitor U0126 (Seger, et al., 
1995) 30 mins before tone-shock conditioning dose-dependently attenuated tone-elicited fear 
when rats were tested 24 hours later. There was no effect of drug during conditioning and 
STM was unaffected. Di Benedetto et al. (2009) replicated this finding in mice using fear-
potentiated startle (FPS) as the measure of conditioned fear. The startle response is evoked 
by an intense, unexpected stimulus (startle pulse; e.g., a brief but loud, sharp noise), and in 
studies with rodents, a whole body jump is usually taken as the magnitude of startle (M. 
Davis et al., 1993). FPS is the increase in startle response when the fear-associated stimulus 
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(e.g., CS previously associated with shock) is present compared to when it is absent. When 
U0126 was infused bilaterally into the LA 30 mins before conditioning, FPS was significantly 
impaired when tested 24 hrs later compared to vehicle infusion (Di Benedetto, et al., 2009). 
Immunohistochemical double-labeling showed that conditioning enhanced pMAPK was 
exclusively found in neuronal cells and not glial cells. In both of these studies, reacquisition 
of conditioned fear after test was not affected, indicating that the infusion of MEK inhibitors 
did not permanently damage the amygdala, and any drug effects were specific to the initial 
fear memory consolidation. Lastly, a study showed that for cued-fear conditioning, MAPK 
phosphorylation is critical not only in the BLA, but also in thalamic inputs into the BLA 
(Apergis-Schoute et al., 2005). In that study, rats were given intra-thalamic infusions of 
U0126 either 30 mins before or immediately after cued-fear conditioning. At both infusion 
intervals, findings revealed that long-term memory to the CS (assessed at 24 h) was 
impaired, whereas short-term memory (assessed at 1–3 h) was intact. In additional 
experiments, it was shown that intra-thalamic infusion of U0126 before LTP-inducing 
stimulation of thalamic inputs to the LA significantly disrupted LTP in the LA. Taken 
together, it appears that MAPK activation in the BLA and its thalamic inputs is critical for 
cued-fear memory consolidation. 
In contrast to the BLA, intra-hippocampal infusion studies provide mixed results. For 
example, bilateral infusion of the MEK inhibitors PD098059 and U0126 into the dorsal 
hippocampus 30 mins before contextual fear conditioning was shown to have no effects on 
STM (tested at 1 hr) and LTM (tested at 24 hrs) (Ahi et al., 2004). On the other hand, 
disruption of the biphasic increase in pERK following context conditioning (at 0-1 h and 9-12 
h post-conditioning) via bilateral infusion of U0126 into the dorsal hippocampus led to an 
impairment in freezing to the context when tested 24 hours following conditioning. STM, 
assessed 1 h after conditioning, was unaffected (Trifilieff et al., 2006). Both of these studies 
were performed in mice. It may be the case that the critical phase of MAPK activation in the 
hippocampus following contextual fear conditioning is rather late (i.e., hours after 
conditioning) compared to MAPK activation in the BLA.  
Despite the inconclusive literature on the necessity of hippocampal MAPK activation on 
contextual fear memory consolidation, findings using the inhibitory step-down avoidance 
task are much clearer. Inhibitory step-down avoidance is a hippocampus-dependent task (I. 
Izquierdo & Medina, 1993), and its training typically involves placing the rat onto a 
platform, and presenting a footshock when the rat steps down. The rat learns to avoid 
stepping down and exploring the box. The latency to step down is used as a measure for 
fear memory in subsequent tests. Izquierdo and his colleagues have shown that bilateral 
infusion of PD098059 into the dorsal hippocampus 180 mins following training significantly 
impaired avoidance performance when tested 24 hrs later (Walz, Roesler, Barros et al., 1999). 
This effect was replicated again in the hippocampus (Walz et al., 2000), as well as in other 
brain structures such as the amygdala, entorhinal and parietal cortices at different time 
intervals following conditioning (Walz, Roesler, Barros, et al., 1999; Walz, Roesler, Quevedo 
et al., 1999; Walz, et al., 2000), suggesting differences in time-specificity of critical MAPK 
activation in different cortical structures. The same researchers also examined hippocampal 
MAPK involvement in the expression of inhibitory learning shortly after training compared 
to long-term memory expression. Bilateral infusion of PD098059 into the dorsal 
hippocampus 10 mins prior to test significantly attenuated retrieval of avoidance memory 
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when the test occurred 31 days after training, whereas STM test 3 hrs following test was 
unaffected (L. A. Izquierdo et al., 2000). This finding complements Kim et al. (2012) that 
showed retrieval of conditioned fear involves phosphorylation of MAPK. It appears that this 
phosphorylation of MAPK is not an indication of memory reconsolidation; rather, it is 
implicated in retrieval processes. Further studies are necessary to disambiguate this issue.   
One study examined whether increasing ERK phosphorylation via an experimental 
manipulation affects fear memory consolidation. Giovannini et al. (2003) first showed that 
bath application of H2 and H3 histamine receptor agonists increased pERK in hippocampal 
brain slices. In a follow-up experiment, rats received bilateral hippocampal infusion of H2 or 
H3 receptor agonists amthamine/RAMH immediately after context-shock training. When 
the rats were tested 72 hours later, both H2 and H3 agonists improved rats' freezing to the 
trained context. Infusions of the MEK inhibitor U0126 blocked any affects of H2 and H3 
agonists, further supporting the idea that any memory enhancement caused by H2/H3 
agonists is due to ERK phosphorylation (Giovannini et al., 2003). Although these results do 
not show that MAPK phosphorylation in the hippocampus is necessary for hippocampal-
dependent learning, they provide some evidence that MAPK phosphorylation in the 
hippocampus plays a critical role in fear memory consolidation. 
Overall, the localized infusion studies described above provide a convincing case for the 
necessity of MAPK in fear conditioning, measured by various types of experimental 
paradigms. Those studies typically used MEK inhibitors that specifically inhibit MAP 
kinases p44MAPK (or ERK1) and p42MAPK (or ERK2) without distinguishing between the 
two. Therefore, research using genetic knockout (KO) or knockdown mouse models 
provided further clues as to which MAPK subtype is particularly important for fear 
learning. In the very first study using the genetic KO model, Sweatt and colleagues 
examined the p44 MAPK/ERK1 KO mice and observed no deficits in their hippocampal 
LTP or contextual- or cued-fear conditioning (Selcher et al., 2001). The authors concluded 
that the effects of MEK inhibition on fear learning must be due to the inhibition of ERK2 
isoform of MAPK rather than ERK1. The same group of researchers then used mutant mice 
that displayed decreased ERK 1/2 phosphorylation in the hippocampus (Shalin et al., 2004). 
The mutant mice showed the same open field, rotarod, shock sensitivity behavior as the 
wildtypes, indicating that their motor coordination, general anxiety, and sensory perception 
were not different from controls. Further, within-session conditioning freezing levels did not 
differ between the mutant and the wildtype. However, the mutant mice displayed 
significant impairment in context-, but not cue-, elicited freezing when tested 24 hours later. 
Recently, a separate group reported that full ERK2 KO mice show almost a 100% prenatal 
mortality rate, thus used a specific ERK2 mutant mouse with partially reduced (20-40%) 
ERK2 (Satoh et al., 2007). Those ERK2 mutant mice showed the same ERK1 level, anatomy 
and synaptic density as wildtypes. There were also no differences in open-field, elevated 
plus maze, Y-maze, wheel-running or circadian activity. Further, no differences were 
observed in within-session freezing during fear conditioning between the mutant and 
wildtype, indicating no differences in shock sensitivity. At test (48 h) however, the mutant 
mice were impaired in both cued- and context-elicited freezing compared to wildtype, 
although there were no differences when measured 2 h after training (STM test). These 
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Taken together, MAPK cascade, especially the one involving the ERK2 isoform, appears 
essential in fear conditioning. There is also overwhelming evidence that MAPK activation 
following learning is critical for memory consolidation and LTM, as STM is not affected by 
MEK inhibition. The next section will review in detail the role of MAPK in an animal model 
of treating anxiety disorders, namely fear extinction.  
3.2 The role of MAPK in extinction of conditioned fear 
At present, the most effective treatment for anxiety disorders is exposure therapies, which 
are based on the process of extinction (Hofmann, 2007). Extinction refers to the decrease or 
suppression in responses expressed to a stimulus due to repeated exposure to that stimulus 
without any reinforcement. As with conditioning, Pavlov was the first person to document 
extinction in the laboratory (see Pavlov, 1927, for review). He observed that animals show a 
robust CR after CS-US pairings; however, the CR dramatically decreased if the CS was 
presented repeatedly without the US. Fear extinction hence refers to the decrease in fear 
conditioned responding due to repeated presentation of the CS without any aversive 
outcome.  
In a typical extinction session, a CS is first paired with a shock, and repeated presentation of 
the CS in the absence of the shock leads to a reduction of conditioned fear both in 
magnitude and frequency. Early theoretical models of Pavlovian conditioning suggested 
that this decreased response to the CS after extinction was due to the ‘unlearning’ or 
‘erasure’ of the original CS-US association (Rescorla & Wagner, 1972). That is, the 
association between the CS and US is severed so that the CS becomes neutral again. 
However, it is now widely believed that the CS-US association remains intact after 
extinction, and that extinction reflects a new learning (CS-no US) process that inhibits the 
original CS-elicited behavior. The primary evidence for this view comes from behavioral 
studies that show performance to an extinguished CS recovers without subsequent re-
training of the CS-US association, namely in the cases of reinstatement, renewal and 
spontaneous recovery (Bouton, 2002). Reinstatement refers to the recovery of extinguished fear 
responses via a pre-test reminder US, usually a footshock. Renewal refers to the recovery of 
extinguished fear responses when the subject is tested outside the extinction context. 
Spontaneous recovery refers to the recovery of extinguished fear responses due to the 
passage of time following extinction training. These findings suggest that extinction is a new 
learning that is mediated by internal, physical and temporal contexts. Strong evidence for 
new learning also comes from pharmacological and molecular studies demonstrating that 
extinction shares similar neural mechanisms with acquisition of learning. Specifically, 
formation of a new long-term memory and extinction are both linked to a molecular cascade 
involving pre-synaptic glutamate release, NMDA-mediated calcium entry, activation of 
protein kinases, gene expression and transcription, and protein synthesis (Baker & Azorlosa, 
1996; Lattal et al., 2006; C. H. Lin, et al., 2001). This molecular cascade has been found to be 
necessary for the consolidation of fear extinction memory in neural structures important for 
extinction. In recent years, local infusion studies, lesion studies, in vivo electrophysiology 
studies and immunohistochemical studies in specific neural structures strongly suggest that 
extinction of conditioned fear involves a circuit including the amygdala and mPFC (Herry & 
Garcia, 2002; Milad & Quirk, 2002; Morgan et al., 1993; Sotres-Bayon et al., 2009). The 
hippocampus has been also incorporated into this neural circuitry, to account for the context 
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effects on extinction (Bouton et al., 2006; Corcoran & Maren, 2001; Myers & Davis, 2007; 
Sotres-Bayon et al., 2006). 
Because extinction is an active learning process that involves many of the neurobiological 
substrates that subserve normal learning and memory, there is now accumulating evidence 
for the involvement of MAPK in extinction of conditioned fear. Indeed, mice exhibit 
significant increases in pMAPK-labelled neurons in the BLA 15, 60 and 360 mins following 
extinction of conditioned freezing responses compared to control groups that were not 
trained or did not receive any extinction (Herry et al., 2006). Additionally, increases in 
phosphorylation of ERK1 and ERK2 are also observed in the hippocampus 15 – 60 mins 
following extinction training compared to untrained mice (Fischer et al., 2007). These 
findings show that extinction triggers MAPK phosphorylation not unlike fear conditioning.  
Interestingly, detecting the activation of MAPK has recently been used to dissociate the 
neural structures involved in extinction of conditioned fear in developing rats. Kim and 
colleagues have provided substantial evidence that fear extinction processes are dissociated 
across development, and have suggested that this is because some neural structures mature 
later than others (Kim & Richardson, 2010). To summarize, P24 rats display adult-like 
extinction in that they show renewal, reinstatement and spontaneous recovery of 
extinguished stimuli. However, pre-weanling aged rats (e.g., P17) do not show any of those 
behavioral phenomena. Pharmacological studies also show that reducing NMDA, -
aminobutyric acid (GABA), and opioid neurotransmission impairs extinction in P24 rats, but 
extinction in P17 rats is only affected by the blocking of opioid neurotransmission. When 
phosphorylation of MAPK was detected using immunohistochemistry, P24 rats showed 
significantly increased pMAPK levels in the amygdala and mPFC compared to untrained, 
reactivated and context-exposure controls 1 hr following extinction (Kim et al., 2009). In 
contrast, extinction in P17 rats led to increases in pMAPK only in the amygdala, but not in 
the mPFC. The authors concluded that the differential involvement of the mPFC as shown 
by MAPK phosphorylation was at least partly responsible for the developmental 
dissociation of extinction-related phenomena. Kim and colleagues also showed that 
adolescent (P35) rats show impairments in long-term extinction of conditioned fear 
compared to pre-adolescent (P24) and adult (P70) rats, a finding that was accompanied by 
significantly lower levels of pMAPK in the infralimbic cortex (IL) of the mPFC in P35 rats 
compared to the other ages 1 hr following extinction training (Kim et al., 2011). Importantly, 
the long-term extinction deficit displayed by adolescent rats was overcome if adolescent rats 
were given double the amount of extinction training, and as a consequence pMAPK levels 
were also increased, supporting the notion that MAPK is directly involved in the 
consolidation of extinction memory. 
The first study that provided evidence for the necessity of MAPK in fear extinction used the 
MEK inhibitor PD98059 for localized infusions (K. T. Lu et al., 2001). In that study, PD98059 
was infused bilaterally into the BLA or the hippocampus 10 mins before extinction training. 
When rats were tested 24 hours later, results showed that BLA, but not hippocampal, 
infusion significantly impaired maintaining the extinction memory. This finding was 
replicated using the MEK inhibitor U0126 (C. H. Lin, Yeh, Lu et al., 2003). In those studies 
FPS was used as a measure for conditioned fear response, which typically does not allow the 
assessment of within-session extinction fear levels due to the obnoxious level of the startle 
pulse. Therefore, it is hard to conclude whether the infusion of MEK inhibitors disrupted 
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fear retrieval and/or extinction acquisition. Using freezing as an index for fear, Herry et al. 
(2006) demonstrated in mice that pre-extinction bilateral infusions of U0126 into the BLA 
completely blocked within-session extinction acquisition compared to vehicle infusion. 
Further, a high level of CS-elicited freezing was maintained at test the next day in the drug 
infusion group. This finding suggests that MAPK is important for the acquisition of 
extinction, rather than its consolidation, which is contrary to the role of MAPK in 
conditioned fear. It may be the case that the role of MAPK phosphorylation in the BLA is 
dissociated across conditioning and extinction.  
In fact, studies indicate that the mPFC, rather than the BLA, is critical for the consolidation 
of fear extinction. For example, immediate, but not late (2 or 4 h), post-extinction infusion of 
PD098059 bilaterally in the mPFC resulted in a full return of conditioned freezing compared 
to vehicle infusions when rats were tested for their long-term extinction (Hugues et al., 
2004). In a follow-up study, Hugues et al. (2006) first showed that hippocampal inputs to the 
mPFC display LTP-like changes following fear extinction compared to before extinction 
training. Further, LTP-like changes were blocked by PD098059 infusion into the mPFC. 
Additionally, Western blot revealed decreases in pERK in the mPFC following PD098059 
infusions. These findings imply that MAPK activation in the mPFC is important for LTP-like 
changes in the mPFC following extinction, which may be the underlying mechanism for 
extinction memory consolidation (Hugues et al., 2006). 
Hippocampal MAPK involvement in fear extinction is still equivocal. For example, Fischer 
et al. (2007) reported that immediate, post-extinction infusion of PD098059 or U0126 both 
impaired long-term extinction of contextual conditioned fear. On the other hand, Izquierdo 
and colleagues found that bilateral infusions of PD098959 prior to extinction only affected 
inhibitory avoidance expression during extinction, without impairing any long-term 
extinction (Szapiro et al., 2003). However, when they infused the p38MAPK inhibitor, 
SB203580, immediately after extinction training of inhibitory avoidance behavior, rats failed 
to show any extinction memory the next day (Rossato et al., 2006). This effect was 
temporally-specific, so that infusion 3 hours following extinction had no effects. The authors 
concluded that unlike inhibitory avoidance conditioning, extinction of inhibitory avoidance 
behavior is not dependent on p44MAPK and p42MAPK activation in the hippocampus. 
Overall, the studies described above provide further support for the idea that fear extinction 
involves a new learning that relies on similar molecular cascades as fear learning. This 
premise led to the discovery that increasing the neurotransmission involved in memory 
consolidation can enhance and facilitate the consolidation of extinguished fear memory. 
Specifically, systemic, as well as intra-BLA, injection of the NMDA partial agonist D-
cycloserine (DCS) facilitates extinction (Walker et al., 2002). It appears that increasing 
NMDA neurotransmission during extinction leads to a stronger extinction memory when 
tested the next day. Follow-up studies clarified that drugs acting on NMDA receptors are 
most likely to be affecting the consolidation of extinction (Ledgerwood et al., 2003; Santini et 
al., 2001). Using freezing as an index of fear, Ledgerwood et al. (2003) demonstrated that 
intra-BLA infusions of DCS had no effect on within-session extinction of conditioned 
freezing compared to vehicle, whilst facilitating extinction at test. Interestingly, this 
facilitation effect of DCS on fear extinction appears to be due, at least partly, to increases in 
MAPK phosphorylation (Matsuda et al., 2010; Yang & Lu, 2005). In Yang and Lu (2005), 
systemic DCS injection 15 mins prior to extinction training significantly facilitated extinction 
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the next day compared to rats injected with saline. Intra-BLA infusion of MEK inhibitors, 
PD098059 or U0126, however, abolished any DCS effects, when infused 5 mins following the 
DCS injection. Western blot revealed that compared to the context-exposure control group, 
extinction training significantly elevated pMAPK in the BLA. Further, administration of 
DCS enhanced the effect of extinction training on MAPK phosphorylation, which in turn 
was blocked by MEK inhibitors. These results strongly suggest that the DCS effect on 
extinction of conditioned fear is mediated by the MAPK-dependent signalling cascades in 
the amygdala. This general finding has been replicated in mice (Matsuda, et al., 2010). 
Taken together, these studies provide compelling evidence for the critical role of MAPK in 
conditioned fear, especially cued-conditioning. There is accumulating evidence indicating 
that fear extinction involves activation and ⁄ or plasticity of inhibitory circuits in the 
amygdala (Chhatwal et al., 2005; Marsicano et al., 2002; Rosenkranz et al., 2003; Royer & 
Pare, 2002). It may be the case that MAPK activation acts directly on the molecular processes 
underlying synaptic plasticity and dendritic integration of neurons in the inhibitory circuit. 
For example, acquisition of extinction and its consolidation are protein synthesis-dependent 
(Berman & Dudai, 2001; C. H. Lin, Lee et al., 2003; Suzuki et al., 2004). Further, recent 
studies implicate the MAPK pathway in controlling rapid local translation during the 
stabilization of newly formed hippocampal memories, which is consistent with a role for 
MAPK ⁄ ERK-mediated control of local protein synthesis during the acquisition of fear 
extinction (Kelleher et al., 2004; Thomas & Huganir, 2004). Importantly, extinction induces 
up-regulation of the protein phosphatase calcineurin in the BLA, which depends on de novo 
protein synthesis (C. H. Lin, Yeh, Lu, et al., 2003). In fact, inhibition of calcineurin interferes 
with extinction (C. H. Lin, Yeh, Leu et al., 2003). Those observations indicate that acquisition 
of extinction may involve, at least in part, a MAPK-dependent control of mRNA translation 
in the BLA. Additionally, MAPK has been implicated in other forms of synaptic plasticity 
including long-term depression (LTD) (G. M. Thomas & Huganir, 2004). Therefore, it may 
be the case that MAPK is necessary not only for the maintenance of CS-no US memory in the 
extinction neural circuitry, but also for the reversal (that is, depotentiation) of fear 
conditioning-induced LTP (H. C. Lin et al., 2010; S. C. Mao et al., 2006; Rosenkranz & Grace, 
2002; Rumpel et al., 2005). In either case, pharmacological modulation of MAPK activation 
could potentially provide novel therapeutic strategies for the treatment for anxiety 
disorders, assuming a lack of off-target effects following long-term systemic treatment.  
4. MAPK and drug addiction 
Drug addiction is more than mere drug use, rather it is a chronic, relapsing disorder that 
consists of a compulsive pattern of drug-seeking and drug-taking behavior that takes place 
at the expense of other activities. A key question in addiction research is identifying what 
changes in the brain underpin the transition from casual to compulsive drug use. Over the 
last 20 years much research has accumulated describing the various long-lasting cellular, 
molecular and neurochemical adaptations which occur with repeated drug administration 
(Kalivas, 2009; Kalivas & O'Brien, 2008; Robinson & Berridge, 1993; M. J. Thomas et al., 
2008). Furthermore, there is a compelling body of evidence linking various models of 
addiction with synaptic plasticity in brain areas involved in reward and reinforcement 
(Kauer & Malenka, 2007; Kelley, 2004).  Drug-induced neuroadaptations are thought to be 
critical in the transition to addiction, though it remains to be fully elucidated how, and to 
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what extent, these changes contribute to prolonged relapse vulnerability after cessation of 
drug use (Shaham & Hope, 2005).  
A central problem facing the treatment of drug addiction is the enduring vulnerability to 
relapse displayed by users despite months or even years of abstinence (Dackis & O'Brien, 
2001; Wagner & Anthony, 2002). Even with successful detoxification, abstinence remains an 
unobtainable goal for many addicted individuals with up to 90% relapsing within 12 
months (DeJong, 1994; Deroche-Gamonet et al., 2004; Gossop et al., 1989). Drug craving, a 
subjective affective state experienced by humans, which motivates them to seek out drugs, is 
associated with relapse propensity (Markou et al., 1993; C. P. O'Brien, 1997a). Craving can be 
induced in addicted individuals by exposure to drug-related paraphernalia, images or 
environmental contexts (A. Childress et al., 1988; Grant et al., 1996). Repeated exposure to 
such cues and contexts during the initiation and maintenance of drug use is therefore 
thought to result in these cues acquiring incentive motivational and conditioned reinforcing 
value (C. O'Brien et al., 1992). Once formed, these pathological associations may ultimately 
contribute to the precipitation of craving and relapse upon re-exposure to drug-associated 
stimuli. In addition to drug-associated cues, relapse can be triggered by other factors such as 
stress and exposure to the drug itself (S. A. Brown et al., 1995; C. O'Brien, et al., 1992).  
Research into potential treatment strategies for addiction, therefore, primarily focuses on 
relapse prevention. Animal models of relapse have yielded invaluable information 
regarding the neurobiology of drug-seeking and the persistent neuroadaptations which 
likely underpin this behavior, revealing a number of key molecules that appear to play a 
critical role. ERK is one of these molecules and the following sections in this chapter will 
cover the evidence which supports a role for ERK in mediating relapse to drug-seeking and 
the drug-induced changes which potentially underlie this behavior.  
4.1 Addiction neurocircuitry  
Despite their varying pharmacological profiles and properties, drugs of abuse all share the 
common feature of acutely enhancing neurotransmission in the mesocorticolimbic 
dopamine system. This interaction can be direct, as in the case of psychostimulants, or 
indirect, as in the case of opioids, but each ultimately result in increased levels of 
extracellular dopamine in the terminal fields of these neurons and this increase in synaptic 
dopamine is thought to be responsible for their reinforcing properties (Di Chiara & 
Imperato, 1988; Wise, 1996). The mesocorticolimbic system is comprised of dopaminergic 
neurons, the cell bodies of which originate in the ventral tegmental area (VTA) and project 
to the nucleus accumbens (NAc) and other limbic regions such as the hippocampus and 
amygdaloid nuclei. A further subdivision of these dopaminergic neurons innervates cortical 
areas including the mPFC, anterior cingulate and orbitofrontal cortices (OFC) (Le Moal, 
1991). Different terminal regions are thought to be involved in the different aspects of 
addictive behavior. The NAc is thought to be involved in the mediation of the acute 
reinforcing effects of drugs (Di Chiara, 2002; Volkow et al., 2003), whereas changes in the 
PFC, OFC and anterior cingulate are related to the decreases in inhibitory control and 
hyper-responsiveness to drug-related cues (Kalivas & Volkow, 2005). The amygdaloid 
nuclei and hippocampus play an important role in conditioning and learning associations 
between drugs and drug-related stimuli (Fuchs et al., 2007; Fuchs et al., 2005; Rogers & See, 
2007; See, 2005).  
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In addition to dopaminergic input, the striatum receives excitatory glutamatergic input from 
the BLA, the hippocampus, the mPFC, the OFC, cingulate cortex and midline thalamic 
nuclei (Alexander et al., 1986). Dopaminergic and glutamatergic inputs converge on the 
dendritic spines of GABAergic striatal efferent neurons (Sesack & Pickel, 1992; Totterdell & 
Smith, 1989). This allows dopamine to play a modulatory role in regulating the excitatory 
input from glutamate to the dendritic spines (A. D. Smith & Bolam, 1990). While dopamine 
is thought to be responsible for the acute effects of addictive drugs, persistent vulnerability 
to relapse is believed to be a result of enduring neuroadaptations in corticostriatal circuitry 
(Kalivas, 2009). The VTA also receives glutamatergic input from structures such as the PFC 
(Omelchenko & Sesack, 2007). Excitatory inputs from the PFC play an important role in 
regulating the activity of VTA neurons and therefore the extracellular levels of dopamine 
within forebrain regions (Carr & Sesack, 2000).  
4.2 The role of MAPK in responses to drug-associated cues and contexts  
A process of classical conditioning occurs with repeated drug use: the multiple cues and 
contexts associated with drug use (previously neutral stimuli) become conditioned stimuli 
(CS) through repeated pairings with the drug (the unconditioned stimulus, US). As this 
learning about drug-associated stimuli develops, the cues gain increasingly greater control 
over behavior and drug-associated cues can acquire the capacity to evoke salient and 
powerful memories of the drug-taking experience that induce craving and ultimately 
relapse (Jentsch & Taylor, 1999). In animals these cues have been shown to increase operant 
drug self-administration and precipitate relapse-like behavior (Aguilar et al., 2009; Crombag 
et al., 2008; Shaham et al., 2003). In the conditioned place preference (CPP) paradigm, a 
variety of species (even crayfish) will preferentially choose to spend more time in an 
environment where they have received a non-contingent injection of drug over an 
environment where they have received vehicle (Nathaniel et al., 2009; Tzschentke, 1998). 
Animal models of relapse have also demonstrated that the motivational properties of drug-
associated stimuli cues can augment or “incubate” over time (Grimm et al., 2001), thereby 
highlighting the need to acknowledge the role of drug-associated cues when developing 
therapeutic interventions.  
CPP is based on classical conditioning principles whereby animals are conditioned to 
associate a distinct environment (i.e., CS) with a drug experience (i.e., US) (Tzschentke, 
1998). A place preference describes a situation where the subject spends more time in a 
drug-paired environment when given the choice after a conditioning period. As researchers, 
we make an inference regarding the rewarding or hedonic properties of a drug based on its 
ability to induce approach (Bardo & Bevins, 2000). Though conditioned approach towards 
specific stimuli, especially drugs of abuse, obviously occurs in humans, this phenomenon 
has never been clinically validated (Bardo, et al., 2000). As with operant self-administration, 
in the reinstatement version of this paradigm the association between the CS and US can be 
extinguished and then reinstated either by non-contingent ‘priming’ injections of the drug 
(Parker & McDonald, 2000) or stress (L. Lu et al., 2002).  In the case of CPP however, there is 
no reinstatement of an instrumental task, rather the reinstatement of conditioned approach 
to the CS (the environment in which the appetitive stimulus was experienced).  
Activation of ERK has been shown to play a role in the associative learning processes that 
occur upon exposure to an environment previously paired with a drug experience.  Thus, ERK 
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activation has been shown to be required for the acquisition of CPP induced by cocaine 
(Valjent et al., 2000), MDMA (Salzmann et al., 2003), THC (Valjent et al., 2001), amphetamines 
(Gerdjikov et al., 2004; Mizoguchi et al., 2004) and morphine (Ozaki et al., 2004), but not 
ethanol (Groblewski, Ryabinin et al., 2011). It is most likely that the NAc is a site of action, at 
least for amphetamines, as intra-NAc injections of the MEK inhibitor PD98059 impair both 
methamphetamine and amphetamine-induced CPP (Gerdjikov, et al., 2004; Mizoguchi, et al., 
2004). This is supported by the observation of increased activation of ERK in the NAc and 
dorsal striatum of mice that have been conditioned to methamphetamine (Mizoguchi, et al., 
2004) and the NAc, dorsal striatum and prefrontal cortex of mice that have been conditioned to 
cocaine (Valjent, Corbille et al., 2006). Another study found that exposing mice to a previously 
cocaine-paired context increased phosphorylation of ERK in the dorsal hippocampus, but not 
the NAc. Enhanced CREB and DARPP-32 phosphorylation in the NAc, however, was 
observed (Tropea et al., 2008). Pre-treatment with the MEK inhibitor SL327 has also been 
shown to abolish the conditioned locomotor response of mice placed in a context previously 
paired with cocaine or D-amphetamine (Valjent, Corvol et al., 2006), indicating the role of ERK 
can be generalised to other contextually-driven behaviors. 
It also appears that the NAc mediates consolidation of learned associations between a drug's 
rewarding effects (US) and the drug-paired context (CS). If rats are injected with a MEK 
inhibitor either systemically or into the NAc core after the test for the expression of cocaine 
or morphine CPP, subsequent CPP is abolished (Miller & Marshall, 2005; Valjent, Corbille, et 
al., 2006). Erasure of CPP expression is accompanied with blockade of ERK phosphorylation 
in the NAc and dorsal striatum (Valjent, Corbille, et al., 2006).  This effect can be mirrored 
with a protein synthesis inhibitor thus providing evidence that ERK exerts this effect on 
memory reconsolidation through regulation of protein synthesis, presumably by controlling 
transcription.  
4.3 The involvement of MAPK in the actions of drugs of abuse & drug-induced 
plasticity   
The MAPK signalling cascade has been implicated in responses to most drugs of abuse, 
supporting the notion that drug-induced plasticity might share common mechanisms with 
learning and memory processes (Berke & Hyman, 2000; Girault et al., 2007; Hyman, 2005). 
ERK is expressed abundantly throughout the brain, including mesocorticolimbic regions 
(Ortiz et al., 1995). Acute and chronic administration of most drugs of abuse such as cocaine, 
morphine, nicotine and Δ9-tetrahydrocannabinol (THC) has been shown to increase 
activation of ERK in reward-related areas such as the VTA, NAc, PFC, central and extended 
amygdala and hippocampus (reviewed in Girault et al., 2007; Zhai et al., 2008). The 
exception is alcohol, where data are equivocal. Acute administration has actually been 
shown to decrease phosphorylation of ERK in the cortex and hippocampus (Chandler & 
Sutton, 2005) but increase phosphorylation in other areas (Bachtell et al., 2002). Chronic 
ethanol intake has been shown to attenuate ERK phosphorylation in the striatum, whereas 
withdrawal for one day potentiates ERK phosphorylation in the same region (Cui et al., 
2011).  
The activation of ERK in response to repeated administration of drugs of abuse suggests 
that ERK plays a role in drug-induced plasticity. One measure of drug-induced plasticity is 
the development and expression of behavioral sensitization (an enhancement of the 
www.intechopen.com
 
The Role of Mitogen-Activated Protein Kinase in Treatment Strategies for Fear and Drug Addiction 
 
351 
psychomotor-activating properties of a drug). Indeed, activation of ERK in the brain 
mesocorticolimbic area has been shown to be involved in sensitization and hence drug-
induced plasticity (Pierce et al., 1999; X. Shi & McGinty, 2006; Valjent, et al., 2000; Valjent, 
Corvol, et al., 2006). Thus, pre-treatment with the MEK inhibitor SL327 prior to the repeated 
administration of cocaine or amphetamine prevents the subsequent expression of sensitization 
to their locomotor-activating effects upon receiving a challenge dose of the drug (Valjent, 
Corvol, et al., 2006). In contrast, the expression of sensitization was not affected when SL327 
was administered before the challenge (Valjent, Corvol, et al., 2006). Therefore it appears ERK 
is more critical for the development of sensitization to psychostimulants. ERK activation in the 
VTA is implicated in this process as intra-VTA infusions of PD98059 attenuate the 
development of sensitization to cocaine (Pierce, et al., 1999).  
ERK in the NAc also appears to be involved in drug-induced plasticity as cocaine sensitized 
rats display increased phospho-ERK2 during withdrawal from cocaine which is normalized 
upon cocaine challenge (Boudreau et al., 2007). ERK2 phosphorylation corresponded with 
accumbens AMPA receptor surface expression (Boudreau, et al., 2007). The authors suggest 
the possibility that ERK contributes to both rapid (LTP) and slowly induced (cocaine 
withdrawal) increases in AMPA receptor surface expression, thus contributing to addiction-
related plasticity (Boudreau, et al., 2007).  Similarly, withdrawal following development of 
sensitization to cocaine has been shown to be associated with time-dependent increases in 
ERK activity which correlate with the increased expression of NMDAR subunits (Schumann 
& Yaka, 2009).  Furthermore, the increase in both GluR1 expression and ERK activity is 
blocked with intra-NAc infusions of a MEK inhibitor 21 d after withdrawal from cocaine. 
These data suggest that the development of cocaine psychomotor sensitization triggers a 
delayed increase in the expression of NMDAR subunits in the NAc, which in turn enhances 
the activity of ERK (Schumann, et al., 2009).  
4.4 Drugs of abuse and mechanisms of ERK signalling  
The activation of ERK by drugs of abuse in mesocorticolimbic regions has been shown to 
require both glutamate and dopamine signalling as it is prevented by both dopamine D1 
and NMDA receptor antagonists (Berhow et al., 1996; Jenab et al., 2005; Valjent, et al., 2000; 
Valjent, et al., 2001; Valjent et al., 2005), and in the case of amphetamine, by group I 
metabotropic glutamate (mGlu) receptor antagonists (Choe et al., 2002).  This is not 
surprising as ERK is found downstream of all these receptors. Thus, the activation of 
dopamine D1 receptors by dopamine increases cyclic adenosine monophosphate (cAMP) 
and thus cAMP-dependent protein kinase A (Bilbao et al. 2008). Activated cAMP-dependent 
protein kinase (Bilbao, et al. 2008) then activates ERK through the the dopamine- and cAMP-
regulated phosphoprotein 32 kDa (DARPP-32) signaling cascade (Greengard et al., 1999; 
Svenningsson et al., 2004). In striatal neurons, the mGlu5 receptor activates ERK through 
Ca2+-dependent and -independent mechanisms, the latter involving the scaffolding protein 
Homer (L. Mao et al., 2005).  Activation of NMDA receptors and the resulting Ca2+ influx 
activate Ca2+/calmodulin-dependent protein kinase II (CaMKII). CaMKII then activates Ras-
GTP, which initiates a number of kinase cascades, including Raf-1, MAPK/ERK kinases and 
ERK (G. M. Thomas, et al., 2004; Xia et al., 1996). ERK is also activated by opioid receptors 
most likely via a mechanism involving Ras and beta-gamma subunits of Gi/o proteins 
(Belcheva et al., 1998). Once activated, ERK translocates to the cell nucleus where it regulates 
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the activity of the transcription factors CREB and Elk-1 which control the transcription of 
many genes implicated in addiction, such as c-fos, ΔFosB, zif268, Homer and 
preprodynorphin (Benavides & Bibb, 2004; Choe & McGinty, 2001; S. Davis, Vanhoutte et 
al., 2000; Girault, et al., 2007; Hurd & Herkenham, 1993; L. Lu, et al., 2006; McClung & 
Nestler, 2003; Nestler, 2001; Radwanska et al., 2005). Downstream effects of many drugs of 
abuse on these genes have been shown to be mediated via ERK (Bachtell, et al., 2002; 
Salzmann, et al., 2003; Valjent, et al., 2000).  
Evidence has accumulated which supports a coincident interaction between D1 and NMDA 
receptors with respect to cocaine-driven ERK signaling in the striatum. Thus, cocaine-
induced ERK activation has been shown to require the coincident stimulation of D1 and 
NMDA receptors (Valjent, et al., 2000; Valjent, et al., 2005) and this appears to be controlled 
by Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1), a neuronal specific activator of 
Ras-ERK signaling (Fasano et al., 2009). The relevance of this Ras-GRF1-mediated ERK 
signaling to reward and drug-induced plasticity is demonstrated by the observation that 
CPP and locomotor sensitization are significantly attenuated in Ras-GRF1–deficient mice, 
and conversely heightened in over-expressing transgenic animals (Fasano, et al., 2009).  
More recently, the D1 or cocaine-mediated activation of ERK in striatal neurons was shown 
to depend on a potentiation of NMDA receptor function independent of cAMP (Pascoli et 
al., 2011). Furthermore, NMDA receptor potentiation involves tyrosine phosphorylation of 
the NR2B subunit via Src-family kinase (SFKs). This mechanism, demonstrated in cultured 
striatal neurons, was also observed in vivo, as ERK phosphorylation in response to D1 
receptor agonism in mice was blocked by pretreatment with an NMDA receptor antagonist 
(Pascoli, et al., 2011). The observed potentiation by the D1 receptor potentially explains why 
NMDA receptor stimulation is required for ERK activation by cocaine and other drugs of 
abuse. As the authors suggest this mechanism has potentially significant functional 
consequences, providing a possible mechanism for facilitation of long-term potentiation of 
glutamatergic synapses in D1 receptor-expressing striatal neurons (Andre et al., 2010; Shen 
et al., 2008). This was evidenced by the attenuation of cocaine-induced sensitization and 
CPP upon inhibition of this D1R/Src family kinases/NR2B pathway (Pascoli, et al., 2011).  
4.5 MAPK in reward learning and synaptic plasticity  
As discussed earlier in this chapter, MAPK has been shown to be intimately involved in 
synaptic plasticity and hence learning and memory processes (for detailed review see G. M. 
Thomas, et al., 2004). As with fear-related disorders, drug addiction has been proposed by 
some to be a form of pathological learning (Berke, et al., 2000).  Reinforcement as a concept 
is ultimately defined by learning processes – it is the strengthening of associations through 
experience. Reinforcement can also be viewed as a process that enhances memory 
consolidation for the association (Landauer, 1969). Either way, it is the “stamping in” (and 
hence learning) of associations that ultimately leads to reinforcement. The associations may 
manifest in a variety of ways: associations between a stimulus and a response (Thorndike, 
1898), associations between a US and CS (I.P. Pavlov, 1927), or associations between a 
response and an outcome (Skinner, 1938). With repeated exposure drugs cause aberrant 
“stamping in” of associations between drug-taking, the resultant drug high and associated 
cues and contexts. 
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The striatum is a key structure which mediates instrumental (action-outcome) learning and 
it is glutamate-dopamine signaling which appears particularly important (Horvitz, 2002). 
Dopamine release in the dorsal striatum is thought to enable coding of action-outcome 
associations facilitating potentiation of corticostriatal synapses during learning (Di Filippo et 
al., 2009; Reynolds et al., 2001). The induction of corticostriatal LTP is dependent on the 
coincident activation of D1 and NMDA receptors (Calabresi et al., 1992; Kerr & Wickens, 
2001; Reynolds, et al., 2001). Thus, corticostriatal LTP has been shown to require activation 
of ERK (Ferguson et al., 2006; Mazzucchelli et al., 2002; Sgambato et al., 1998) and indeed, 
the requirement for coincident activation of NMDA and D1 receptors for ERK activation has 
led some to propose that ERK functions to selectively induce plasticity at corticostriatal 
synapses during highly salient learning situations like reward learning, when coordinated 
dopamine and NMDA receptor activation is likely to occur (Girault, et al., 2007; Shiflett & 
Balleine, 2011).  
The involvement of ERK in instrumental learning and corticostriatal LTP (Shiflett et al., 
2010; G. M. Thomas, et al., 2004) suggests that ERK may play a role in the action-outcome 
learning which occurs with initial drug use. Indeed, a recent study showed that clinically 
relevant concentrations of ethanol dose-dependently attenuated the high frequency 
stimulation-induced LTP and ERK activation in the dorsomedial striatum (Xie et al., 2009). 
Relatively little is understood regarding synaptic plasticity in habit formation, but it may 
involve corticostriatal LTD (Shiflett, et al., 2011). The induction of LTD in the striatum was 
recently shown to require ERK activation (Cui, et al., 2011) which matches with findings 
regarding LTD in other brain regions such as hippocampus (Thiels et al., 2002). This recent 
study also showed that chronic ethanol intake by rats attenuated both ERK phosphorylation 
and LTD induction, whereas withdrawal for one day potentiated ERK phosphorylation and 
LTD induction (Cui, et al., 2011). By showing that chronic ethanol intake and withdrawal 
differentially altered synaptic plasticity in the dorsolateral striatum through the ERK 
signaling pathway, these findings suggest that chronic alcohol use may impact on the habit-
formation process, and this neural maladaptation may consequently lead to habitual drug-
seeking behavior (Cui, et al., 2011).   
Persistent vulnerability to relapse in addiction is thought to be a result of a specific 
impairment in LTD at cortico-accumbal synapses (Kasanetz et al. 2010; Martin et al., 2006; 
Moussawi et al., 2009). In addition to LTD, cortico-accumbal LTP is abolished in vivo after 
withdrawal from cocaine self-administration (Knackstedt et al., 2010; Moussawi, et al., 2009) 
The loss of both LTP and LTD in vivo after cocaine self-administration has led to the 
hypothesis that the inability of the medium spiny neurons in the NAc core to undergo 
bidirectional prefrontal-induced neuroplasticity may reduce the capacity of drug addicts to 
adaptively organize a behavioral response that incorporates environmental contingencies 
that mediate against relapse (Kalivas, 2009; M. J. Thomas, et al., 2008). The following section 
will describe the literature supporting a role for ERK in relapse to drug-seeking behavior. 
4.6 The involvement of MAPK in drug-seeking behavior  
The operant self-administration procedure is a widely accepted model to study drug 
reinforcement and drug-seeking because it has both face and construct validity (Feltenstein 
& See, 2008). In the operant paradigm the animal is trained to perform an instrumental task 
to self-administer a drug (generally by pressing a lever or via a nose-poke) for a period of 
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time, thereby developing an action-outcome association between the operant task and the 
ensuing reward (conditioned response). Rodents will readily self-administer most drugs of 
abuse, including cocaine (R. M. Brown & Lawrence, 2009; McPherson et al., 2010). 
Accordingly, the abuse potential of a substance in humans can be predicted from self-
administration in rodents (Collins et al., 1984). Moreover, similar to the laboratory model of 
anxiety disorders, the self-administration paradigm can incorporate a Pavlovian 
conditioning component by introducing CSs that signal drug delivery to represent 
cues/contexts that are critically related to relapse of drug-seeking (Adams et al., 2010; Jupp 
et al., 2011).  
4.6.1 The role of MAPK in the reinstatement model of drug-seeking  
As with extinction of fear, the reinforced response (e.g. lever press) can be subsequently 
extinguished whereby no drug is administered despite the animal responding on the drug-
paired manipulandum. Responding will typically spike in what has been termed an 
‘extinction burst’ and then gradually decline to a level whereby the behavior is deemed 
extinguished. Extinction learning is an active process that reduces the value or salience of 
these conditioned cues and contexts. Longer and repeated cue/contextual re-exposure 
without the associated fear or drug experience reduces conditioned responding. Extinction 
learning can be effective for reducing cue- and context-induced symptoms in addiction and 
anxiety and can improve outcomes in these disorders. Reinstatement of drug-seeking 
behavior as measured by responding on the drug-paired manipulandum can be precipitated 
in a number of ways: with non-contingent ‘priming’ injections of the drug (Stretch et al., 
1971), stressors (Carroll, 1985; Shaham & Stewart, 1996), and drug-associated cues (W. M. 
Davis & Smith, 1976).  In humans, drug craving and relapse have shown to be triggered by 
similar factors (S. A. Brown, et al., 1995; C. O'Brien, et al., 1992), giving this model an 
element of construct validity. This model also exhibits predictive validity, as drugs such as 
naltrexone that decrease relapse in abstinent drug users also decrease reinstatement of drug 
seeking behavior in rats (Comer et al., 2006) 
As mentioned previously, drug-associated cues induce ERK phosphorylation in components 
of the mesocorticolimbic system (L. Lu et al., 2005; Miller, et al., 2005) and ERK has been 
shown to play a role in drug-induced and synaptic plasticity (G. M. Thomas, et al., 2004; 
Valjent, Corvol, et al., 2006) thus it is not surprising that evidence exist that support a role 
for ERK in cue-elicited reinstatement of drug-seeking. Cue-induced reinstatement of 
alcohol-seeking is associated with enhanced activation of ERK in the BLA and NAc shell 
(Schroeder et al., 2008). The mGlu5 receptor antagonist 2-Methyl-6-(phenylethynyl)pyridine 
(MPEP) was shown to block both the cue-induced drug-seeking and the associated increase 
in phospho-ERK (Schroeder, et al., 2008), indicating that ERK activation is dependent on  
mGlu5 receptor signalling and plays a key role in the effect of MPEP on drug-seeking.  
A recent study demonstrated a critical role for ERK in the ability of BNDF infusions in the 
dmPFC to attenuate reinstatement of both cue-induced and primed cocaine-seeking, as well 
as cocaine-seeking following abstinence (Whitfield et al., 2011). Vehicle-infused rats showed 
significant decreases in phospho-ERK and CREB at the end of the cocaine self-
administration period that were reversed by intra-dmPFC BDNF. This ability of BDNF to 
reverse cocaine-mediated decreases in ERK and CREB phosphorylation was blocked by both 
the MEK inhibitor U0126 and the tyrosine kinase inhibitor K252a, thus demonstrating the 
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behavioral effects of BDNF were most likely mediated via a TrkB receptor-ERK pathway. 
This study elucidates a mechanism whereby BDNF/TrkB activates ERK-regulated CREB 
phosphorylation in the dmPFC to counteract the neuroadaptations induced by cocaine self-
administration and subsequent relapse to cocaine-seeking (Whitfield, et al., 2011). 
There are no studies as yet which have specifically examined the role of ERK in extinction 
learning related to operant responding. There is one CPP study that showed heightened 
ERK activation in the amygdala following extinction of cocaine-induced CPP (Chen & Xu, 
2010), which is consistent with fear extinction literature showing a key role for the amygdala 
(Myers, et al., 2007). In addition, dopamine D3 receptor mutant mice showed delayed CPP 
extinction compared with wild-type mice and this was associated with sustained ERK 
activation in the NAc and PFC (Chen, et al., 2010). This suggests that extinction of cocaine 
conditioning involves dopamine D3 receptor/ERK signaling though this finding is not 
necessarily readily generalized to other drugs of abuse as the MEK inhibitor SL327 has been 
shown to have no effect on extinction of an ethanol-induced CPP in mice (Groblewski, 
Franken et al., 2011). 
4.6.2 The role of MAPK in the abstinence model of relapse and incubation of craving  
Of the millions of people suffering from addiction, only a small proportion actually seek 
treatment in a formal setting. For example, in 2009 out of 23.5 million Americans who were 
considered to have an illicit drug or alcohol use problem, only 2.6 million (11.2%) received 
treatment at a specialty facility (SAMHSA, 2010). In this sense then, the reinstatement model 
of relapse is only relevant to those addicts who engage in new learning to overcome their 
addiction. The bulk of drug dependent individuals will attempt to overcome their addiction 
by simply attempting to abstain from drug use (also known as going ‘cold turkey’). 
Therefore another relevant model of relapse is one that measures drug-seeking following a 
period of abstinence.  
In 1986 it was suggested that in humans, craving induced by drug cues actually increases 
over the first several weeks of the withdrawal period and remains elevated over extended 
periods of abstinence (Gawin & Kleber, 1986). Scientists have since discovered an analogous 
phenomenon in laboratory animals which has been termed ‘incubation of craving’. It has 
been demonstrated with opiates (Shalev et al., 2001), psychostimulants (Grimm, et al., 2001; 
Shepard et al., 2004) and ethanol (Bienkowski et al., 2004), that cue-induced drug-seeking 
increases over time over the first months of withdrawal. This phenomenon has also been 
observed with the natural reinforcer sucrose (Grimm et al., 2002), though in this case the 
effect peaks after 1–4 weeks, but decays after 2 months, while for cocaine, the responding 
peaks after 1 month and persists for up to 3 months in rats (L. Lu et al., 2004). In humans, 
this incubation of drug craving ultimately results in an increased propensity to relapse as a 
function of time spent in withdrawal. A more appropriate paradigm for this sort of relapse 
behavior is a modification of the reinstatement model known as the abstinence model (e.g. 
Brown et al., 2009; Lu et al., 2009; reviewed in Reichel and Bevins, 2009). After a period of 
self-administration the animal undergoes withdrawal for a period of time (typically a 
number of weeks) in the home cage. At the end of this period drug-seeking behavior is 
measured by re-introducing the subject to the operant chamber and measuring responding 
under extinction conditions (i.e. in the absence of drug).  
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Numerous cellular and molecular changes are produced by chronic drug use, which are 
thought to regulate drug-seeking behavior, yet only a small number thus far have been 
shown to be associated with time-dependent increases in drug-seeking behavior. One of 
these neuroadaptations is activation of ERK. Studies by Lu and colleagues have revealed 
that it is ERK phosphorylation in the CeA, but not BLA, that underpins incubation of 
cocaine and opiate craving as inhibition of CeA, but not BLA, ERK phosphorylation 
decreases drug-seeking after 30 days of drug withdrawal but not after 1 day of withdrawal 
(Li et al., 2008; L. Lu, et al., 2005). After 30 withdrawal days, inhibition of CeA ERK 
phosphorylation by U0126 or the NMDA receptor antagonist AP-5 decreased cue-induced 
cocaine seeking.  
Subsequently, other studies have shown a similar enhancement of ERK phosphorylation in 
the NAc core (Edwards et al., 2011) and mPFC (Koya et al., 2008) as a result of exposure to a 
cocaine-paired context after extended abstinence in animals that had previously self-
administered cocaine. In the former study, the activation of ERK was found only in rats that 
had self-administered cocaine and not their yoked controls, demonstrating the effect was 
not merely the result of cocaine exposure (Edwards, et al., 2011). Though the precise role of 
increased ERK activity in the NAc and mPFC in incubation of craving remains to be 
investigated, a key role for ERK in the amygdala has been found in Pavlovian fear 
conditioning and memory reconsolidation (Nader et al., 2000). ERK in the amygdala also 
appears to be critically involved in the long-term neuroadaptations which result in 
heightened reactivity to drug-associated cues. This is supported by the observation that re-
exposure to an ethanol-associated context and discrete cues following abstinence increases 
activation of ERK in the BLA and ventral lateral amygdala (Radwanska et al., 2008). 
Collectively, these findings indicate that activation of ERK, particularly in the amygdala 
appears to be a key substrate for incubation of drug craving.  
5. Concluding remarks 
The studies highlighted in the present chapter clearly demonstrate the learning and memory 
principles underlying fear and drug-seeking behavior. Additionally, drug addiction has 
been emphasized as a brain disorder that involves enduring neuroadaptations that alter 
signal transduction within neurons as well as electrical and chemical communications 
between neurons and neural structures. Considering the significance of the MAPK cascade 
in cellular growth, differentiation and neuronal survivability (Ahn & Krebs, 1990; Hoshi et 
al., 1988; Impey et al., 1999; Kornhauser & Greenberg, 1997), perhaps it is not surprising that 
MAPK signalling also plays a seemingly important role in both the acquisition and 
treatment of anxiety and drug-seeking behavior as pointed out in the present chapter. Given 
the prevalence and financial burden of anxiety disorders and drug addiction, we propose 
that further research into the MAPK signalling cascade could be a fruitful strategy in finding 
effective treatments for anxiety disorders and drug addiction. 
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